Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 565367, 6 pages
http://dx.doi.org/10.1155/2014/565367
Clinical Study

Atorvastatin Combining with Probucol: A New Way to Reduce Serum Uric Acid Level during Perioperative Period of Interventional Procedure

1Graduate School, Tianjin Medical University, Tianjin 300051, China
2Department of Geriatrics, The First Hospital of Qinhuangdao, Qinhuangdao 066000, China
3Department of Cardiology, Tianjin Chest Hospital, Tianjin Medical University, Xi’an Road No. 93, Heping District, Tianjin, 300051, China
4Cardiology Department, Dagang Oil Field General Hospital, Tianjin Medical University, Tianjin 300051, China

Received 19 August 2013; Accepted 4 November 2013; Published 29 January 2014

Academic Editors: C. L. Athanasuleas, H. Kitabata, and Y. Murakawa

Copyright © 2014 Hong Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. McCullough and S. S. Soman, “Contrast-induced nephropathy,” Critical Care Clinics, vol. 21, no. 2, pp. 261–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. P. B. Persson, P. Hansell, and P. Liss, “Pathophysiology of contrast medium-induced nephropathy,” Kidney International, vol. 68, no. 1, pp. 14–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Detrenis, M. Meschi, S. Musini, and G. Savazzi, “Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art,” Nephrology Dialysis Transplantation, vol. 20, no. 8, pp. 1542–1550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. S. Perlstein, O. Gumieniak, P. N. Hopkins et al., “Uric acid and the state of the intrarenal renin-angiotensin system in humans,” Kidney International, vol. 66, no. 4, pp. 1465–1470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Toprak, M. Cirit, E. Esi, N. Postaci, M. Yesil, and S. Bayata, “Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease,” Catheterization and Cardiovascular Interventions, vol. 67, no. 2, pp. 227–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Özhan, I. Erden, S. Ordu et al., “Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography,” Angiology, vol. 61, no. 7, pp. 711–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Shepherd, J. J. Kastelein, V. Bittner et al., “Effects of intensive lipid lowering with atorvastatinon renal function: the treating to new targets study,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 6, pp. 1131–1139, 2007. View at Google Scholar
  8. L. Yin, G.-P. Li, T. Liu et al., “Role of probucol in preventing contrast induced acute kidney injury after coronary interventional procedure: a randomized trial,” Chinese Journal of Cardiovascular Diseases, vol. 37, no. 5, pp. 385–388, 2009. View at Google Scholar · View at Scopus
  9. Cardiovascular branch of Chinese Medical Association and Chinese Journal of cardiology editor committee, “chronic stable angina pectoris diagnosis and treatment guidelines,” Chinese Journal of Cardiology, vol. 35, no. 3, pp. 195–206, 2007. View at Google Scholar
  10. Cardiovascular branch of Chinese Medical Association and Chinese Journal of cardiology editor committee, “Unstable angina and non ST segment elevation myocardial infarction diagnosis and treatment guidelines,” Chinese Journal of Cardiology, vol. 35, no. 3, pp. 295–304, 2007. View at Google Scholar
  11. Cardiovascular branch of Chinese Medical Association and Chinese Journal of cardiology editor committee, “Recommendation the use of universal definition of myocardial infarction in China,” Chinese Journal of Cardiology, vol. 36, no. 10, pp. 867–869, 2008. View at Google Scholar
  12. R. Mehran and J. Kahn, “Contrast-induced nephropathy remains a serious complication of PCI,” Journal of Interventional Cardiology, vol. 20, no. 3, pp. 236–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. P. A. McCullough, “Beyond serum creatinine: defining the patient with renal insufficiency and why?” Reviews in Cardiovascular Medicine, vol. 4, supplement 1, pp. S2–S6, 2003. View at Google Scholar · View at Scopus
  14. The task force for he management of arterial hypertension of the European Society of hypertension (ESH) and of the European Society of Cardiology (ESC), “2007 Guidelines for the management of arterial hypertension,” Journal of Hypertension, vol. 25, no. 6, pp. 1105–1187, 2007. View at Google Scholar
  15. K. A. Sterling, T. Tehrani, and M. R. Rudnick, “Clinical significance and preventive strategies for contrast-induced nephropathy,” Current Opinion in Nephrology and Hypertension, vol. 17, no. 6, pp. 616–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Amini, M. Salarifar, A. Amirbaigloo, F. Masoudkabir, and F. Esfahani, “N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial,” Trials, vol. 10, article 45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. W. Murphy, B. J. Barrett, and P. S. Parfrey, “Contrast nephropathy,” Journal of the American Society of Nephrology, vol. 11, no. 1, pp. 177–182, 2000. View at Google Scholar · View at Scopus
  18. T. G. Gleeson and S. Bulugahapitiya, “Contrast-induced nephropathy,” The American Journal of Roentgenology, vol. 183, no. 6, pp. 1673–1689, 2004. View at Google Scholar · View at Scopus
  19. A. E. Postlethwaite and W. N. Kelley, “Uricosuric effect of radiocontrast agents: a study in man of four commonly used preparations,” Annals of Internal Medicine, vol. 74, no. 6, pp. 845–852, 1971. View at Google Scholar · View at Scopus
  20. G. H. Mudge, “Uricosuric action of cholecystographic agents: a possible factor in nephrotoxicity,” The New England Journal of Medicine, vol. 284, no. 17, pp. 929–933, 1971. View at Google Scholar · View at Scopus
  21. D.-H. Kang, E. S. Yu, J.-E. Park et al., “Uric acid induced C-reactive protein expression via upregulation of angiotensin type 1 receptors in vascular endothelial cells and smooth muscle cells,” Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 3553–3562, 2005. View at Google Scholar
  22. R. J. Johnson, D.-H. Kang, D. Feig et al., “Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?” Hypertension, vol. 41, no. 6, pp. 1183–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ruggiero, A. Cherubini, A. Ble et al., “Uric acid and inflammatory markers,” European Heart Journal, vol. 27, no. 10, pp. 1174–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler, “Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam Study,” Stroke, vol. 37, no. 6, pp. 1503–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. R. P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, and R. Klauser-Braun, “Elevated uric acid increases the risk for kidney disease,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2407–2413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Sundström, L. Sullivan, R. B. D'Agostino, D. Levy, W. B. Kannel, and R. S. Vasan, “Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence,” Hypertension, vol. 45, no. 1, pp. 28–33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Zhang, L.-H. Shen, L.-H. Hu, and B. He, “Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis,” The American Journal of Nephrology, vol. 33, no. 4, pp. 344–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Xinwei, F. Xianghua, Z. Jing et al., “Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention,” The American Journal of Cardiology, vol. 104, no. 4, pp. 519–524, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. X. Zhou, Y.-Z. Jin, Q. Wang, R. Min, and X.-Y. Zhang, “Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography,” Chinese Journal of Cardiovascular Diseases, vol. 37, no. 5, pp. 394–396, 2009. View at Google Scholar · View at Scopus
  30. J. Z. Su, Y. Xue, W. Q. Cai et al., “Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin,” Chinese Journal of Cardiovascular Diseases, vol. 39, no. 9, pp. 807–811, 2011. View at Google Scholar
  31. S. Khanal, N. Attallah, D. E. Smith et al., “Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions,” The American Journal of Medicine, vol. 118, no. 8, pp. 843–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Patti, A. Nusca, M. Chello et al., “Usefulness of statin pretreatment to prevent contrastinduced nephropathy and to improve long-term outcomes in patients undergoing percutaneous coronary intervention,” The American Journal of Cardiology, vol. 101, no. 3, pp. 279–285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. J. Milionis, A. I. Kakafika, S. G. Tsouli et al., “Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia,” The American Heart Journal, vol. 148, no. 4, pp. 635–640, 2004. View at Publisher · View at Google Scholar · View at Scopus